Avelas Biosciences is a clinical-stage biotechnology company and a pioneer in the field of intraoperative fluorescent cancer imaging. The company is focused on developing pegloprastide (also known as AVB-620), a novel drug-device combination product for use during cancer surgery. Pegloprastide is designed to improve surgery by detecting cancer in real time and has the potential to become part of standard-of-care treatment for a variety of cancer surgeries.
Avelas Biosciences Address
11099 N Torrey Pines Rd La Jolla, CA United States